Experimental Cancer Drug Displays Potential in a Number of Rare Cancers
MALCOLUMBUS / Pixabay

Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

According to a story from EurekAlert!, a new type of cancer drug that is being described as a "Trojan horse" that infiltrates cancer tumors is showing potential in several types…

Continue Reading Experimental Cancer Drug Displays Potential in a Number of Rare Cancers

Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It

According to a story from metro.co.uk, celebrity Katie Price, an English television personality, author, singer, and designer is reportedly considering part time residential care for her son Harvey. Harvey has…

Continue Reading Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It
Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?
stevepb / Pixabay

Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

According to a story from Andre Eger, the drug developer Gilead recently had the misfortune to announce that its clinical trial testing an experimental drug for late stage nonalcoholic steatohepatitis…

Continue Reading Clinical Trials for Nonalcoholic Steatohepatitis Drugs Are Beginning to Proliferate, But Are They Any Good?

Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

According to a study published in the Orphanet Journal of Rare Diseases, a study that was intended to identify a new approach to monitoring the progression of x-linked adrenoleukodystrophy in women…

Continue Reading Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

Sexual Abuse in Medical Research: How Can Justice be Served?

Content Warning: The following article discusses sexual abuse. According to a story from Buzzfeed News, many former patients of an esteemed medical researcher named Reginald Archibald, who was affiliated with…

Continue Reading Sexual Abuse in Medical Research: How Can Justice be Served?

Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

According to a story from IT Business Net, the medical company KIYATEC, Inc., has recently announced that that the Knight Cancer Institute at Oregon Health & Science University has joined…

Continue Reading Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

New Treatment for GEP-NETs Approved in Canada

According to a story from pm360online.com, the Novartis company Advanced Accelerator Applications S.A. recently announced that Health Canada has issued approval for Lutathera™ as a treatment for gasteroenteropancreatic neuroendocrine tumors…

Continue Reading New Treatment for GEP-NETs Approved in Canada
4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
birgl / Pixabay

4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome

According to a story from abc13.com, Makenna Brown, a four-year-old girl from Texas, has been plagued by relentless itching thanks to her Alagille syndrome, a rare genetic disorder. Her distressed…

Continue Reading 4-Year-Old Girl Joins Clinical Trial to Relieve Itching Associated With Alagille Syndrome
The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
johnhain / Pixabay

The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

According to a story from pm360online.com, The National Brain Tumor Society (NBTS) recently awarded $750,000 to the Global Coalition for Adaptive Research. This cash is slated to go towards the…

Continue Reading The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
sabinurce / Pixabay

Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia

According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…

Continue Reading Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME
marusya21111999 / Pixabay

Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME

According to a story from The ME Association, a recent debate that came to the floor of the UK parliament highlights the misinformation and deficits in care surrounding children with…

Continue Reading Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME
Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial
PhotoLizM / Pixabay

Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial

According to a story from pm360online.com, the life sciences company Solid Biosciences has released some preliminary findings from its Phase 1/2 clinical trial of SGT-001. This investigational product is in…

Continue Reading Company Releases Early Data and Plans to Boost Dose in Duchenne Muscular Dystrophy Trial